en sv

Stem cell research


Category

Ghost hearts could relieve the shortage of donor organs

Ghost hearts could relieve the shortage of donor organs

Tailor-made organs for human heart transplants using a patient’s own stem cells. This could mean an end to all organ shortages and anti-rejection drugs, as well as a revolution in cardiovascular surgery.

Cellaviva Sverige December 17, 2020
Cancer and Alzheimer's disease, two sides of the same coin

Cancer and Alzheimer's disease, two sides of the same coin

“Cancer and Alzheimer’s disease are like two sides of the same coin. The mechanisms are very similar, but the opposite of each other,” says Maria Ankarcrona, researcher at Karolinska Institutet’s Alzheimer’s Center in Huddinge.

Cellaviva Sverige December 8, 2020
Interview in the magazine Kids & Family with one of our Cellaviva families

Interview in the magazine Kids & Family with one of our Cellaviva families

“As a becoming mother, you want to be able to sign a contract with ‘the existence’ that nothing terrible can happen to your child. Unfortunately, reality does not look like that and we live in a time where life factors and the environment affect life “, answers Anja to the question why they believe that stem cell saving was an important step at the birth of their daughter.

Cellaviva Sverige December 1, 2020
What do atomic bombs and stem cells have in common?

What do atomic bombs and stem cells have in common?

The people exposed to nuclear fallout from the atomic bombs dropped on Hiroshima and Nagasaki during World War II suffered catastrophic health problems long after the actual explosions, which led researchers (who were looking for cures) to make an incredible discovery.

Cellaviva Sverige December 1, 2020
Allogeneic cell therapy has once again shown efficacy in type 1 diabetes

Allogeneic cell therapy has once again shown efficacy in type 1 diabetes

“Our vision is to improve treatment options for thousands, maybe millions of patients and reducing healthcare costs with the aid of stem cell therapy.” Mathias Svahn, CEO of Cellaviva and NextCell Pharma.

Cellaviva Sverige October 20, 2020
ProTrans shows significant effect in Diabetes

ProTrans shows significant effect in Diabetes

Cellaviva's parent company NextCell Pharma AB ("NextCell") today announces that the ProTrans-2 clinical trial met the primary endpoint. Patients treated with a single dose ProTrans show a statistically significant improved...

Cellaviva Sverige September 8, 2020
Type 1 diabetes treatment with umbilical cord stem cells

Type 1 diabetes treatment with umbilical cord stem cells

NextCell expects ProTrans to be an effective treatment for autoimmune diseases NextCell expects ProTrans to be an effective treatment for autoimmune diseases, other inflammatory conditions and in transplant reactions following...

Cellaviva Sverige June 8, 2020
Crown Princess Victoria awards research prize to Cellaviva's Principal investigator

Crown Princess Victoria awards research prize to Cellaviva's Principal investigator

Cellaviva and NextCell Pharma's Principal investigator receive the award as Child Diabetes Researcher of the Year by Swedish Crown Princess Victoria. Cellaviva's Principal investigator for both our clinical studies with...

Cellaviva Sverige June 5, 2020